Instructor of Medicine Harvard Medical School. Executive Officer The Alliance for Clinical Trials in Oncology Foundation

Oncology

Dr. Otto Metzger, MD

Otto Metzger works in the field of Oncology. He has 1 awards "Clinical Scholar Award". Otto Metzger is a published doctor and has 30 publications published. The lastest was: 'Challenges in launching multinational oncology clinical trials in India.'

Publications

Challenges in launching multinational oncology clinical trials in India.
Pertuzumab: optimizing HER2 blockade.
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII...
Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.
Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzu...
Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial.
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-...
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.
Genomic grade adds prognostic value in invasive lobular carcinoma.
Prevention and management of major side effects of targeted agents in breast cancer.
Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?
SnapShot: breast cancer.
Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.
Targeted therapies in breast cancer: are heart and vessels also being targeted?
The natural history of hormone receptor-positive breast cancer.
Dissecting the heterogeneity of triple-negative breast cancer.
Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma.
Benefit-risk assessment of bevacizumab in the treatment of breast cancer.
Neoadjuvant chemotherapy and targeted therapies: a promising strategy.
Beyond trastuzumab: new treatment options for HER2-positive breast cancer.
Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis.
Molecular targeted therapy in prevalent tumors: learning from the past and future perspectives.
Management of metastatic HER2-positive breast cancer progression after adjuvant trastuzumab therapy - current evidence and future trends.
Changing the clinical picture of challenging tumors: tales becoming reality?
Larotaxel: broadening the road with new taxanes.
[Thyrotoxic hypocalemic periodic paralysis: report of 3 cases].

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Awards

Clinical Scholar Award

Hospital

Dana-Farber Cancer Institute

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Steven L. McAfee, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Yariv J. Houvras, MD This Doctor is OpenDoctor Recommended.
	Christine Legler This Doctor is OpenDoctor Recommended.
	Dr. Craig C. Earle, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Leroy M. Parker, MD This Doctor is OpenDoctor Recommended.
	Dr. John Koreth, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Alphonse G. Taghian, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Steven J. Isakoff, MD This Doctor is OpenDoctor Recommended.
	Dr. Philip C. Amrein, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Bruce J. Dezube, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Anumeha Gupta, MD This Doctor is OpenDoctor Recommended.